Filing Details
- Accession Number:
- 0001689375-24-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-30 16:32:11
- Reporting Period:
- 2024-09-26
- Accepted Time:
- 2024-09-30 16:32:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689375 | Entrada Therapeutics Inc. | TRDA | Pharmaceutical Preparations (2834) | 813983399 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1873392 | J Nathan Dowden | C/O Entrada Therapeutics, Inc. One Design Center Place, Suite 17-500 Boston MA 02210 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-09-26 | 847 | $16.00 | 125,149 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024.
Billionaire Hedge Funds
